The work of the Partnership is centered on the goal of improving health outcomes for pregnant women and their babies in West Virginia.
The essential source of information upon which the initiatives of the Partnership are based is obtained from the Key Informant Survey. The first Key Informant Survey was conducted in 2006 to gain input from medical, nursing and other individuals serving pregnant women and their babies in both rural and urban areas about their opinions regarding why West Virginia has one of the highest rates of infant mortality and low birth weight babies in the nation.Learn More
PUBLICATION: Novel Withdrawal Symptoms of a Neonate Prenatally Exposed to a Fentanyl AnalogJanuary 2, 2019
Thomas Memorial Hospital Introduces Grace’s ClosetDecember 18, 2018
ABC News report highlights WVU Medicine’s care for drug-exposed babiesOctober 23, 2018
PUBLICATION: Researchers capture the incidence of NAS in West VirginiaOctober 16, 2018
CURRENT NEWS & EVENTS
Treatment Services for Pregnant Women with Substance Use DisordersLearn More
Improving Care for Newborns with Substance Exposure and Neonatal Abstinence Syndrome (NAS)
The West Virginia Perinatal Partnership seeks to provide a better understanding of the extent and cost of the problem of perinatal substance use and to help implement effective interventions to reduce the impact. With funding from the Claude W. Benedum Foundation, and in collaboration with the Department of Health and Human Resources and many other state partners, the Perinatal Partnership is implementing a Quality Improvement initiative aimed at improving the identification, diagnosis and treatment of substance exposed infants in West Virginia.
Improving the identification of Substance Exposed Infants in WV is presented by Sean Loudin, MD of Cabell Huntington Hospital, Stefan Maxwell, MD of CAMC’s Women and Children’s Hospital, and Collin John, MD of Ruby Memorial, West Virginia University.See the Presentation
Pregnant or thinking about becoming pregnant and worried about Zika?
The Zika virus continues to generate concern among all people, particularly pregnant women and their practitioners. With the identification of local transmission within the continental United States, this concern has grown. This article is a brief overview of information available and links to reliable resources for patients and practitioners.Learn more